Hence, vaccines or drugs modulating IL-18, IP-10, FLT3L, MCP-1, MCP-2, and MIP-3β expression might be promising novel tools to induce early antiviral responses to combat acute SIV/HIV infection. This evidence concerns the gene CCL19 and HIV infectious disease.